𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The p53 Arg72Pro and MDM2 -309 polymorphisms and risk of breast cancer in the nurses’ health studies

✍ Scribed by David G. Cox; Dwayne Deer; Qun Guo; Shelley S. Tworoger; Susan E. Hankinson; David J. Hunter; Immaculata De Vivo

Publisher
Springer Netherlands
Year
2007
Tongue
English
Weight
135 KB
Volume
18
Category
Article
ISSN
0957-5243

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A haplotype containing the p53 polymorph
A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers
✍ A. Osorio; B. Martínez-Delgado; M. Pollán; M. Cuadros; M. Urioste; C. Torrentera 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

## Communicated by Dvorah Abeliovich Germline mutations in the BRCA1 and BRCA2 genes confer a high lifetime risk of developing breast and other cancers; however, remarkable differences exist regarding disease manifestation in mutation carriers. It has been suggested that other genetic and/or enviro

Risk of MDM2 SNP309 alone or in combinat
Risk of MDM2 SNP309 alone or in combination with the p53 codon 72 polymorphism in acute myeloid leukemia
✍ Xiujuan Xiong; Min Wang; Lin Wang; Jiazhuo Liu; Xin Zhao; Zheng Tian; Jianxiang 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 160 KB

A single nucleotide polymorphism (SNP) in the promoter of MDM2 gene, SNP309 T>G (a T-G exchange at nucleotide 309 in the first intron), can increase the expression level of MDM2, thereby causing an impairment of p53 tumor suppressor activity. A G-C exchange at p53 codon 72 polymorphism results in a

Polymorphisms at p53, p73, and MDM2 loci
Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer
✍ Chaitali Misra; Mousumi Majumder; Swati Bajaj; Saurabh Ghosh; Bidyut Roy; Susant 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

## Abstract Polymorphisms at loci controlling cellular processes such as cell cycle, DNA repair, and apoptosis may modulate the risk of cancer. We examined the association of two linked polymorphisms (G4C14–A4T14) at __p73__ and one polymorphism (309G > T) at __MDM2__ promoter with the risk of leuk